Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
2.110
+0.010 (0.48%)
Dec 20, 2024, 4:00 PM EST - Market closed
Harvard Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -14.24 | -3.42 | -9.52 | -0.29 | -7.81 | -4.69 | Upgrade
|
| Depreciation & Amortization | 7.17 | 7 | 7.58 | 7.62 | 7.63 | 7.73 | Upgrade
|
| Other Amortization | 0.3 | 0.28 | 0.28 | 0.28 | 1.18 | 0.39 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.4 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 1.46 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.63 | 0.63 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 4.76 | 5 | 4.41 | 4.17 | 3.65 | 3.03 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | - | 0.29 | Upgrade
|
| Other Operating Activities | 1.13 | 0.34 | -4.31 | -0.33 | 0.58 | -0.21 | Upgrade
|
| Change in Accounts Receivable | 2.36 | 0.81 | 4.78 | -4.29 | 3.11 | 0.47 | Upgrade
|
| Change in Inventory | -1.07 | 1.52 | 0.25 | -5.86 | 0.41 | 3.26 | Upgrade
|
| Change in Accounts Payable | 0.57 | 0.56 | -1.4 | 2.45 | 1.49 | -2.05 | Upgrade
|
| Change in Unearned Revenue | -0.32 | 1.14 | -0.9 | 0.51 | -0.18 | 0.12 | Upgrade
|
| Change in Other Net Operating Assets | 1.5 | 0.57 | -0.02 | -2.99 | -0.72 | -1.76 | Upgrade
|
| Operating Cash Flow | 4.02 | 14.03 | 1.15 | 1.26 | 9.33 | 8.05 | Upgrade
|
| Operating Cash Flow Growth | -67.61% | 1117.71% | -8.72% | -86.48% | 15.99% | 178.95% | Upgrade
|
| Capital Expenditures | -3.17 | -1.79 | -1.59 | -1.2 | -1.15 | -1.22 | Upgrade
|
| Divestitures | - | 0.51 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.69 | -0.52 | - | -0.15 | -0.25 | - | Upgrade
|
| Other Investing Activities | - | - | - | - | - | 0.99 | Upgrade
|
| Investing Cash Flow | -1.94 | -1.8 | -1.59 | -1.35 | -1.4 | -0.23 | Upgrade
|
| Long-Term Debt Issued | - | 4.5 | 7.8 | 4.25 | 61.32 | 4.3 | Upgrade
|
| Long-Term Debt Repaid | - | -15.04 | -9.59 | -4.2 | -66.91 | -11.7 | Upgrade
|
| Net Debt Issued (Repaid) | -1.02 | -10.54 | -1.79 | 0.05 | -5.6 | -7.4 | Upgrade
|
| Issuance of Common Stock | 0.43 | 0.93 | 0.58 | 3.31 | 0.67 | - | Upgrade
|
| Repurchase of Common Stock | -2.13 | -2.52 | -1.63 | -3.51 | -1.14 | -0.22 | Upgrade
|
| Other Financing Activities | -0.16 | - | - | -0.1 | -1.9 | - | Upgrade
|
| Financing Cash Flow | -2.89 | -12.13 | -2.84 | -0.25 | -7.97 | -7.62 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.04 | -0.32 | -0.04 | -0.16 | 0.02 | -0.03 | Upgrade
|
| Net Cash Flow | -0.77 | -0.23 | -3.31 | -0.5 | -0.02 | 0.16 | Upgrade
|
| Free Cash Flow | 0.85 | 12.24 | -0.44 | 0.07 | 8.18 | 6.83 | Upgrade
|
| Free Cash Flow Growth | -92.46% | - | - | -99.18% | 19.77% | 259.80% | Upgrade
|
| Free Cash Flow Margin | 0.86% | 10.90% | -0.39% | 0.06% | 8.01% | 5.88% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.29 | -0.01 | 0.00 | 0.21 | 0.18 | Upgrade
|
| Cash Interest Paid | 3.16 | 3.8 | 2.31 | 1.58 | 4.88 | 5.5 | Upgrade
|
| Cash Income Tax Paid | 0.35 | 0.21 | 0.53 | 0.58 | 0.42 | 0.37 | Upgrade
|
| Levered Free Cash Flow | 6.06 | 13.11 | 10.35 | 4.41 | 12.53 | 8.75 | Upgrade
|
| Unlevered Free Cash Flow | 7.73 | 15.07 | 11.66 | 5.09 | 14.37 | 11.75 | Upgrade
|
| Change in Net Working Capital | -2.33 | -3.83 | -4.51 | 7.66 | -3.09 | -0.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.